SCHEMBL6132584

SCHEMBL6132584

COc1ccc(C=C2NC(=O)CN(C(C)=O)C2=O)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
HRH3 Q9Y5N1 1/20 0.52
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 3/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PSMB5 P28074 3/20 0.44
PSMB1 P20618 2/20 0.44
GAA P10253 3/20 0.43
CBS P35520 1/20 0.42
POLB P06746 1/20 0.42
BRD4 O60885 2/20 0.41
BRD2 P25440 1/20 0.41
PSMB2 P49721 1/20 0.40
NPC1 O15118 1/20 0.39
MDM4 O15151 1/20 0.39
JAK2 O60674 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132582 1.00 KMT2A (0.53) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL6132671 0.92 KMT2A (0.52) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL6132674 0.92 KMT2A (0.52) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL5371735 0.84 MEN1 (0.48) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL5371732 0.84 MEN1 (0.48) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL8411264 0.83 HRH3 (0.64) KMT2AMEN1HRH3ALDH1A1PSMB5
SCHEMBL8411263 0.83 HRH3 (0.64) KMT2AMEN1HRH3ALDH1A1PSMB5
SCHEMBL8573167 0.83 HRH3 (0.64) KMT2AMEN1HRH3ALDH1A1PSMB5
SCHEMBL6133031 0.81 MEN1 (0.56) KMT2AMEN1HRH3ALDH1A1MAPT
SCHEMBL6133033 0.81 MEN1 (0.56) KMT2AMEN1HRH3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 KMT2A 829/4885MEN1 1830/4885HRH3 229/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 KMT2A 1097/4885MEN1 1520/4885HRH3 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.